EXACT SCIENCES CORP 4 SEC Filings

Filed On	Filing
23 Mar 2026	Form 4: Baranick Brian, EVP, GM, Precision Oncology Received 33,321 shares as a grant or award · Returned 137,990 shares to the issuer · Disposed of 28,063 Restricted Stock Units (Disposition to Issuer)
23 Mar 2026	Form 4: Herriott James, SVP, General Counsel & Sec Returned 69,957 shares to the issuer · Disposed of 3,654 Stock Options (Right to Buy) (Disposition to Issuer) · Disposed of 20,321 Restricted Stock Units (Disposition to Issuer)
23 Mar 2026	Form 4: Bloomer Aaron, EVP, Chief Financial Officer Received 89,911 shares as a grant or award · Returned 139,096 shares to the issuer · Disposed of 32,458 Restricted Stock Units (Disposition to Issuer)
23 Mar 2026	Form 4: Condella Sarah, EVP, Human Resources Received 60,389 shares as a grant or award · Returned 198,259 shares to the issuer · Disposed of 48,019 Stock Options (Right to Buy) (Disposition to Issuer) · 1 more
23 Mar 2026	Form 4: Conroy Kevin T, Director Received 119,312 shares as a grant or award · Returned 1,677,514 shares to the issuer · Disposed of 436,461 Stock Options (Right to Buy) (Disposition to Issuer) · 1 more
23 Mar 2026	Form 4: Orville Jacob A, EVP, GM, Screening Received 53,323 shares as a grant or award · Returned 155,500 shares to the issuer · Disposed of 6,581 Stock Options (Right to Buy) (Disposition to Issuer) · 1 more
23 Mar 2026	Form 4: Coward D Scott, Director Returned 62,256 shares to the issuer · Disposed of 27,836 Stock Options (Right to Buy) (Disposition to Issuer)
23 Mar 2026	Form 4: Petrovic Shacey, Director Returned 28,899 shares to the issuer
23 Mar 2026	Form 4: Zanotti Katherine S, Director Returned 60,759 shares to the issuer
23 Mar 2026	Form 4: Popovits Kimberly J, Director Returned 16,381 shares to the issuer
23 Mar 2026	Form 4: Doyle James Edward, Director Returned 57,962 shares to the issuer
23 Mar 2026	Form 4: Clancy Paul J, Director Returned 26,038 shares to the issuer
23 Mar 2026	Form 4: Barber Michael J, Director Returned 13,136 shares to the issuer · Disposed of 7,422 Deferred Stock Units (Disposition to Issuer)
23 Mar 2026	Form 4: Trigg Leslie, Director Returned 17,169 shares to the issuer
03 Mar 2026	Form 4: Conroy Kevin T, Director Received 68,097 shares by exercise or conversion · Gave up 32,007 shares to cover exercise price or tax ($3.3M)
03 Mar 2026	Form 4: Condella Sarah, EVP, Human Resources Received 3,900 shares by exercise or conversion ($19.6K) · Gave up 1,913 shares to cover exercise price or tax ($198K)
27 Feb 2026	Form 4: Condella Sarah, EVP, Human Resources Granted 23,224 Restricted Stock Units
27 Feb 2026	Form 4: Herriott James, SVP, General Counsel & Sec Granted 20,321 Restricted Stock Units
27 Feb 2026	Form 4: Conroy Kevin T, Director Received 13,181 shares as a grant or award · Gave up 6,196 shares to cover exercise price or tax ($641K) · Granted 154,829 Restricted Stock Units
27 Feb 2026	Form 4: Baranick Brian, EVP, GM, Precision Oncology Granted 28,063 Restricted Stock Units

Comments